Intranasal Oxytocin Attenuates Reactive and Ongoing, Chronic Pain in a Model of Mild Traumatic Brain Injury

ConclusionsIntranasal oxytocin attenuates measures of reactive and non‐reactive pain in a model of mild TBI and may represent a novel treatment for chronic pain in TBI patients.

Source: Headache: The Journal of Head and Face Pain - November 1, 2017 Category: Neurology Authors: Anders C. Meidahl, Andreas Eisenried, Michael Klukinov, Longhui Cao, Alexander Z. Tzabazis, David C. Yeomans Tags: Research Submissions Source Type: research